Table 1. Baseline Characteristics of Participants Treated for Alcohol or Opioid Use Disorder by Medication Prescribed (2005).

	Acamprosate Cohort (N=10,309)		Naltrexone Cohort (N=4,389)		Buprenorphine Cohort (N=3,320)		Methadone Cohort (N=5,449)
Characteristic	N	%	N	%	N	%	N	%
Sex
Women	3,304	32.1	1,585	36.1	885	26.7	2,123	39.0
Men	7,005	67.9	2,804	63.9	2,435	73.3	3,326	61.0
Age (years)
<20	295	2.9	230	5.2	216	6.5	113	2.1
20–29	748	7.3	456	10.4	1,253	37.7	802	14.7
30–39	1,651	16.0	792	18.1	983	29.6	1,110	20.4
40–49	2,817	27.3	1,161	26.5	675	20.3	1,441	26.5
50–59	2,859	27.7	1,019	23.2	169	5.1	946	17.4
60–69	1,613	15.6	595	13.6	21	0.6	946	10.7
>69	326	3.2	136	3.1	3	0.1	453	8.3
Sociodemographic variables
Unmarried or divorced	6,469	62.8	3,015	68.7	2,862	89.5	3,575	69.9
Employed	5,313	51.5	1,782	40.6	639	19.8	1,202	22.5
Receiving social welfare	1,441	14.0	825	18.8	1,961	60.9	1,825	34.1
Receiving disability pension	2,674	25.9	1,406	32.0	650	20.2	2,076	38.8
Lifetime psychiatric and substance use
disorder diagnoses
Alcohol use disorder	7,685	74.6	3,426	78.5	1,146	34.5	1,251	23.0
Substance use disordera	2,359	22.9	1,478	33.7	3,293	99.2	3,343	61.4
Psychotic disorders	966	9.4	745	17.0	330	9.9	334	6.1
Bipolar disorder	896	8.7	583	13.3	160	4.8	188	3.5

^aIn this category, we report substance use disorders other than alcohol use disorder.